Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL

Author： Yerbes Rosario  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.30, Iss.2, 2012-04, pp. : 541-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Histone Deacetylase Inhibitor, MS-275 (Entinostat), Downregulates c-FLIP, Sensitizes Osteosarcoma Cells to FasL, and Induces the Regression of Osteosarcoma Lung Metastases

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 411-422

Bentham Science Publishers

Access to resources Recommend Favorite

Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis

By Williams Robert J  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1571-1573

Informa Healthcare

Access to resources Recommend Favorite

Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells

By Oh Eun-Taex  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor

By  

Current Cancer Drug Targets, Vol. 15, Iss. 6, 2015-01 ,pp. : 493-503

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of a Histone Deacetylase Inhibitor on Human Cardiac Mass

By Shizukuda Yukitaka   Piekarz Richard   Bates Susan   Sachdev Vandana   Finkel Toren   Rosing Douglas  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 89-90

Springer Publishing Company

Access to resources Recommend Favorite